Allogene Therapeutics, Inc. (ALLO) vs Altimmune, Inc. (ALT)
A side-by-side comparison of Allogene Therapeutics, Inc. and Altimmune, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ALT
Altimmune, Inc.
$2.67HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLO vs ALT
growth of $100 · dividends reinvested · last 8yALLO -94.0% (-29.6%/yr)ALT -42.3% (-6.6%/yr)ALT compounded faster over this window
Log scale — wide-divergence pair
ALLO ALT
ALLO vs ALT: by the numbers
- •ALT is the larger company ($519M vs $518M market cap).
- •Both run net losses; ALLO's is the smaller (-3566.68% vs -296000.00% net margin).
- •Both shrank revenue over the past five years; ALLO's decline was smaller (-34.47% vs -65.38% CAGR).
Metrics side by side
Valuation
| Metric | ALLO | ALT |
|---|---|---|
| P/S ratio | 111.58 | 16749.86 |
| P/B ratio | 1.19 | 1.09 |
Profitability
| Metric | ALLO | ALT |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -230460.98% |
| Net margin | -3566.68% | -296000.00% |
| ROE | -37.94% | -19.35% |
| ROIC | -34.79% | -19.47% |
Growth (annualized)
| Metric | ALLO | ALT |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | -65.38% |
| Total return CAGR (5Y) | -42.72% | -25.30% |
Frequently asked
- Which has grown faster, ALLO or ALT?
- Neither grew: over the past five years both shrank revenue, with ALLO's decline the smaller — ALLO at a -34.47% CAGR versus ALT at -65.38%.
- How have ALLO and ALT total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and ALT delivered -25.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.